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doi:10.1016/j.kjms.2011.06.027Abstract Very few reports are available from the literature related to Enterococcus hirae
infection in humans, which is more frequently seen in animals and birds. We report two
patients with E hirae bacteremia caused by acute pyelonephritis and acute cholangitis. The
clinical courses have been smooth on use of sensitive antibiotic therapy. In both cases, the
primary sources and portals of entry are clearly identified.
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The genus Enterococcus was separated from the genus
Streptococcus after being first described by Schleifer and
Kilpper-Ba¨lz in 1984. Enterococcus faecalis and E faecium,
as other members of the genus that form part of human
autochthonous microflora [1], are the most frequently
encountered pathogens causing severe infections, such as
urinary tract infections (UTIs) and infective endocarditis.f Gastroenterology, Depart-
edical University, Wanfang
ng Road, Taipei 116, Taiwan.
(G.-S. Lien).
vier Taiwan LLC. All rights reservThe incidence of E hirae among human clinical isolates is
between 1% [2] and 3% [3], which is one of the lowest
for the genus Enterococcus. We herein report two cases of
E hirae-related bacteremic infection. In both cases, the
bacterial species were confirmed by molecular and genetic
methods.Case presentation
Case 1
The patient was a 62-year-old female senior high-school
teacher who was single and lived alone in Taipei. She haded.
112 T.-S. Chan et al.constipation for which she occasionally took laxatives. She
had never been hospitalized before and she had not been
taking any antibiotic agent before admission. She had
suffered a 5-day fever and chills that persisted despite
having taken over-the-counter medications. Symptoms of
urinary irritation developed later and she visited our
hospital. At the hospital, the patient was found febrile
(39.1C). The physical examination was unremarkable but
there was prominent punch tenderness over the right
costovertebral angle. A urinalysis disclosed the presence of
80e90 white blood cells (WBCs) per high-power field. The
urine protein and leukocyte esterase reaction were both
strongly positive. A hemogram showed leukocytosis (WBC:
14,140/mL) with left shift. The patient was admitted and
cultures were obtained from blood and urine. She was
empirically treated with intravenous cefazolin and genta-
micin first. The urine and blood culture data showed
Enterococcus sp, which was further identified as E hirae
with BD Phoenix ID/AST Panel Inoculation System; BD
(Becton Drive), Franklin Lakes, NJ, USA. The antibiotic
sensitivity profiles were identical, showing sensitivity to
ampicillin. Ampicillin was then subsequently given. An
abdominal sonogram showed gallbladder stones but unre-
markable kidneys. Her fecal analysis was normal. As her
condition improved, the patient was discharged on Day 5 of
hospitalization and continued with oral amoxicillin for 7
days, totalizing a 12-day treatment. For microbiological
identification, strains from blood and urine were sub-
cultured on blood agar plates/eosin methylene blue agar
and named as EH-1. The polymerase chain reaction (PCR)
with muramidase-2 (mur-2) gene gave a product of 521
base pairs, which was not visible on amplified E faecium
DNA (Fig. 1A). To genetically confirm the identity of the
bacteria, the amplifiedmur-2 gene sequence was compared
with the publicly available BLAST sequence databaseFigure 1. (A) Polymerase chain reaction of the two Entero-
coccus hirae strains (EH-1 and EH-2) together with E faecium
using the mur-2 primers. Amplification products of 521 base
pairs can only be seen for the E hirae DNA but not for the E
faecium DNA. (B) Pulsed-field gel electrophoresis of ApaI-
digested genomic DNA from EH-1 and EH-2 showed a close
kinship between the two isolates. mur-2Zmuramidase-2;
PFGEZ pulsed-field gel electrophoresis.(http://www.ncbi.nlm.nih.gov/blast) [4], showing a 98e99%
similarity. To the best of our knowledge, this is the first
reported case of an E hirae-related acute pyelonephritis (AP)
with bacteremia in humans.
Case 2
The second case involves an 86-year-old woman with
congestive heart failure, hypertension, valvular heart
disease, parkinsonism, dementia, and a recent history of
hospitalization because of Pseudomonas aeruginosa-related
UTI. Fever recurred 3 weeks after her latest discharge. On
arrival, the patient was hypotensive, febrile, tachycardiac,
and tachypneic. The conjunctivae were pink but the sclera
and skin were yellowish. The abdomen was soft and showed
tenderness over the right upper quadrant. The hemogram
showed leukocytosis (WBC 13,620/mL) with left shift. The
urinalysis was normal. The laboratory examination dis-
closed the following: aspartate aminotransferase/alanine
aminotransferase: 882/1,105 U/L, alkaline phosphatase/
gamma-glutamyl transferase: 335/1,305 U/L, and total
bilirubin/direct bilirubin: 5.14/3.13 mg/dL. A sonogram
revealed dilations of bilateral intrahepatic ducts and
common bile duct. She was provided with cefmetazole
empirically under the clinical suspicion of acute chol-
angitis. An endoscopic retrograde cholagiopancreatography
showed common bile duct stones, which were retrieved
successfully after endoscopic papillotomy. On the subse-
quent days, her blood culture yielded E hirae (named as
EH-2), with pertinent confirmation as with the Case 1. The
serology tests were negative for hepatitis B and hepatitis
C. Her condition improved and the patient was discharged
on Day 16 of hospitalization. She was kept with oral anti-
biotic for 23 days in total.
Discussion
Enterococci are gram-positive, catalase-negative, non-
spore-forming, facultative anaerobic bacteria. The
Enterococcus genus comprises 37 different species. E fae-
calis and E faecium are the most important ones for their
frequency of occurrence and pathogenic role. Five groups
have been identified in the genus, namely the E faecalis sp
group; the E faecium sp group, which include E hirae; the
E avium sp group; the E gallinarum sp group; and the
ungrouped enterococci [5]. Enterococcus sp are an essen-
tial part of the microflora of both humans and animals.
They inhabit the alimentary tract [6], subsequently,
enterococci are found mainly in the feces of healthy adults.
Enterococci can also be found in vaginal and oral speci-
mens. These bacteria were used to be considered innoc-
uous and were used in the preparation of alimentary
products, such as cheese or sausage. However, the impor-
tance of enterococcal infections has been appealing
attention of epidemiologists and microbiologists. First, an
unobserved rising incidence was reported recently by the
Health Protection Agency of the United Kingdom in 2007.
Second, the generation of drug-resistant Enterococcus sp
has been increasing in humans.
E hirae was first described by Farrow and Collins [7] in
1985, when they found that these bacteria caused growth
Table 1 The primers used for the PCR identification of the Enterococcus hirae and E faecium isolates.
Gene PCR product (base pairs) Primer name Primer sequence
mur-2 521 mur-2-F þCGTCAGTACCCTTCTTTTGCAGAGTC
mur-2-R GCATTATTACCAGTGTTAGTGGTTG
van-A 732 van-A-F þGGGAAAACGACAATTGC
van-A-R GTACAATGCGCCTTA
van-B 635 van-B-F þATGGGAAGCCGATAGTC
van-B-R GATTTCGTTCCTCGACC
Figure 2. Polymerase chain reaction of EH-1, EH2, and
vancomycin-resistant enterococcus (VRE). The products of 732
base pairs was visible only in VRE, corroborating with the
antibiotic sensitivity test indicating that the isolated EH-1 and
EH-2 are not intrinsically vancomycin resistant. The VRE used
are E faecium carrying vanA only.
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numerous reports in animals and birds, but very limited
cases were found in humans. The incidences of E hirae were
reported to be around 1% (0.2e3%) of all enterococcal
infections, probably underestimated because of inadequate
identification [2,3,8,9]. Interestingly, E hirae has a higher
isolation rate in particular regions of Europe, such as
Sweden and Denmark [10].
Enterococcal infections include UTI, hepatobiliary
infection, endocarditis, surgical wound infection, bacter-
emia, and neonatal sepsis [11]. E hirae has been reported
to cause wound infection [12] and gastritis [13] in humans.
There have been only three cases of E hirae bacteremic
infection reported in the literature. These were found in
patients with end-stage renal disease [14], native valve
endocarditis [15], and spondylodiscitis [16]. The first case
was reported in 1998 when a 49-year-old male undergoing
renal replacement therapy was found to have a positive
blood culture. The second case was a 72-year-old male with
aortic valve endocarditis-related bacteremia, which
required surgical intervention after a failed antibiotic
treatment course. The third case was a 55-year-old diabetic
patient with spondylodiscitis. A culture of the surgical
specimen showed E hirae. The actual portals of entry for
E hirae remained unclear in these patients.
AP refers to an upper UTI with the involvement of renal
parenchyma and renal pelvis. AP has a wide spectrum of
clinical presentations, ranging from mild disease to fatal
septicemia. The diagnosis of AP is clinical, based on
evidence of UTI from urinary analysis and culture, along
with signs and symptoms suggesting upper UTI, such as
fever, chills, flank pain, nausea, vomiting, and costoverte-
bral angle tenderness [17,18]. Enterococci are important
causative agents of nosocomial UTI. When endocarditis is
not present, the urinary tract represents the most frequent
sources of enterococcal bacteremia. So far, there have
been no reports of E hirae-related AP or biliary tract
infection in the literature.
The predisposing risk factors for enterococcal bacter-
emic infection have been reported to previous antibiotic
treatment, diabetes mellitus, neurological conditions,
heart disease, renal disease, pressure sores, and malig-
nancy. Medical instrumentations, such as urinary cathe-
terization, vascular access, endoscocopy, mechanical
ventilation, and surgical operation, were found to be
associated with enterococcal infections as well. In biliary
tract infection, bacteria gain access to the biliary tree from
the duodenum or from portal venous blood. Any conditions
that promote bile stasis, for example cholelithiasis, or any
damage occurring to intestinal barrier may predispose to
cholangitis. There is no bile culture to demonstrate thepresence of E hirae from the second patient. However, in
view of patient’s clinical presentations, cholangitis still
remains the most probable original site of E hirae
bacteremia.
Because of phenotypic and biochemical similarities,
many genetic diagnostic methods have been developed to
specifically identify the different components of the
Enterococcus genus. Most of them were to differentiate
between E faecalis and E faecium. The mur-2 gene codes
for a 74-kDa peptidoglycan hydrolase that plays a role in
the cell wall growth and division [19]. The gene was cloned,
sequenced, and used to specifically identify E hirae from
other enterococcus. We successfully identified EH-1 and
EH-2 with mur-2. The similar restriction pattern obtained
from pulsed-field gel electrophoresis with restriction
enzyme ApaI hints for genomic similarity and relatedness
between them (Fig. 1B). The primers used for the PCR
identification of E hirae and E faecium are listed in Table 1.
Independent of the virulence and the pathogenicity, an
important feature of Enterococcus sp resides in their
acquisition of drug resistance, especially to glycopeptide
agents, such as vancomycin or teicoplanin. Robredo et al.
114 T.-S. Chan et al.[20] had demonstrated that E hirae may be a significant
source of vancomycin resistant gene, vanA, and may carry
the potential to spread the gene to other enterococcal
species that infect humans or animals. In the first case, the
antibiotic sensitivity profiles were identical for the bacteria
got from blood and urine. Meanwhile, the antibiotic sensi-
tivity profiles between EH-1 and EH-2 were very similar:
sensitive to teicoplanin, vancomycin, and high-dose
gentamicin but resistant to oxacillin and gentamicin. To
look inside if the isolated E hirae are intrinsically vanco-
mycin resistant, a PCR was performed among EH-1, EH-2,
and vancomycin-resistant enterococcus. The vancomycin-
resistant enterococcus used is a vanA gene carrying
E faecium. Neither EH-1 nor EH-2 carries the resistant gene,
corroborating the antibiotic sensitivity test (Fig. 2).
In summary, our cases constitute the first descriptions of
E hirae-related human diseases, specifically AP and acute
cholangitis, both of which are complicated with bacter-
emia. The clinical courses have been smooth on use of
sensitive antibiotic therapy. These two cases further
expand the spectrum of diseases caused by Enterococcus
sp. More importantly, they are the first reports of E hirae-
related infections in which the primary sources of infection
and portals of entry can be clearly identified.
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